HEXO Corp to transfer listing to the New York Stock Exchange
July 11 2019 - 7:17AM
HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE-A: HEXO) is
pleased to announce it has received approval from the New York
Stock Exchange (the “NYSE”) to transfer the listing of its common
shares from the NYSE American LLC (the “NYSE-A”) to the NYSE. HEXO
expects to begin trading on the NYSE effective at the open of
markets on July 16, 2019.
HEXO’s shares will trade on the NYSE under the
ticker symbol “HEXO”, the same symbol the Company’s common shares
currently trade under on the NYSE-A, as well as the Toronto Stock
Exchange (the “TSX”). HEXO’s shares will continue to trade on the
TSX under such symbol.
"We are extremely pleased to list on the NYSE
and believe it reaffirms HEXO’s strong track-record for exceptional
corporate governance and is further proof that we are a valuable
cannabis industry partner for Fortune 500 companies," said CEO and
co-founder Sebastien St-Louis. “HEXO is well-positioned to support
consumer packaged goods companies looking to enter the space given
our success in the industry, our established infrastructure
including a manufacturing centre of excellence in Ontario, Canada,
our technology to support mass-scale extraction and processing of
advanced cannabis products, and our regulatory expertise.”
In connection with the listing of its common
shares on the NYSE, the Company will voluntarily delist its common
shares from the NYSE-A.
About HEXO Corp.
HEXO Corp is an award-winning consumer packaged
goods cannabis company that creates and distributes innovative
products to serve the global cannabis market. Through its hub and
spoke business strategy, HEXO Corp is partnering with Fortune 500
companies, bringing its brand value, cannabinoid isolation
technology, licensed infrastructure and regulatory expertise to
established companies, leveraging their distribution networks and
capacity. As one of the largest licensed cannabis companies in
Canada, HEXO Corp operates with 2.4 million sq. ft of facilities in
Ontario and Quebec. The Company is also expanding internationally.
The Company serves the Canadian adult-use markets under its HEXO
Cannabis and Up Cannabis brands, and the medical market under HEXO
medical cannabis. For more information please visit
hexocorp.com.
Forward-Looking Information
This press release contains forward-looking
information and forward-looking statements within the meaning of
applicable securities laws (“forward-looking statements”).
Forward-looking statements are based on certain expectations and
assumptions and are subject to known and unknown risks and
uncertainties and other factors that could cause actual events,
results, performance and achievements to differ materially from
those anticipated in these forward-looking statements.
Forward-looking statements should not be read as guarantees of
future performance or results. A more complete discussion of the
risks and uncertainties facing the Company appears in the Company’s
Annual Information Form and other continuous disclosure filings,
which are available on SEDAR at www.sedar.com and EDGAR at
www.sec.gov. Readers are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date
of this press release. The Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking statements as a result of new
information or future events, or for any other reason.
Investor Relations:Jennifer
Smith1-866-438-8429invest@HEXO.com www.hexocorp.com
Media Relations:Caroline Milliard(819)
317-0526media@hexo.com Director:Adam
Miron819-639-5498
HEXO (TSX:HEXO)
Historical Stock Chart
From Aug 2024 to Sep 2024
HEXO (TSX:HEXO)
Historical Stock Chart
From Sep 2023 to Sep 2024